首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1705671

疫苗市場按類型、技術、適應症、給藥途徑及地區分類

Vaccines Market, By Type, By Technology, By Disease Indication, By Route of Administration, By Geography

出版日期: 2025年02月19日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球疫苗市場規模為 819.1 億美元，到 2032 年將達到 1,248.8 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 6.2%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	819.1億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	6.20%	2032年價值預測	1248.8億美元

數字。 2025年各地區疫苗市場佔有率（%）

由於各種感染疾病的流行程度不斷提高以及疫苗生產技術的進步，全球疫苗市場在過去幾年中一直穩步成長。疫苗有助於增強對某些疾病的免疫力，並保護高風險族群免受危險感染疾病的致命影響。人們對疫苗接種的認知不斷提高，尤其是在開發中國家，這推動了全球對先進且價格合理的疫苗的需求。此外，各大廠商推出的聯合疫苗也促進了疫苗接種覆蓋率的提高，減輕了醫療資源的壓力。預計預測期內各國政府和國際組織對疫苗接種計畫的持續支持將推動全球疫苗市場的成長。

市場動態：

全球疫苗市場主要受到感染疾病率上升、疫苗製造技術進步以及政府對疫苗接種計劃日益重視的推動。根據世界衛生組織 (WHO) 統計，疫苗接種每年可防止約 200 萬至 300 萬人死亡。此外，針對某些疾病的強制疫苗接種和全球消滅疾病的努力也為市場成長提供了動力。然而，新疫苗研發成本高、監管核准程序嚴格、以及因錯誤訊息而猶豫接種疫苗等因素阻礙了疫苗的廣泛應用。同時，無需冷藏即可承受高溫的耐熱疫苗、可提供針對變異病毒保護的細胞疫苗技術以及增加中低收入國家疫苗接種率的舉措的開發預計將在未來幾年為企業帶來豐厚的機會。

本研究的主要特點

本報告對全球疫苗市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模（以十億美元為單位）和年複合成長率（CAGR%），假設 2024 年為基準年。

它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

本報告根據公司亮點、產品系列、主要成就、財務表現和策略等參數，提供了全球疫苗市場主要企業的概況。

研究涉及的主要企業包括輝瑞、默克、賽諾菲巴斯德、GlaxoSmithKline Plc(GSK)、Astra Zeneca、強生、CSL 有限公司和印度血清研究所。

本報告提供的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球疫苗市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

透過分析全球疫苗市場所使用的各種策略矩陣，相關人員將更容易做出決策。

北美洲
美國
加拿大
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第10章競爭格局

GlaxoSmithKline plc（GSK）
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Moderna, Inc.
AstraZeneca
Johnson & Johnson
Novavax, Inc.
CSL Limited
Emergent BioSolutions Inc.
Bharat Biotech
Serum Institute of India
BioNTech SE
Takeda Pharmaceutical Company
Sinovac Biotech Ltd.
Sinopharm（China National Pharmaceutical Group）
Vaxart, Inc.
Inovio Pharmaceuticals, Inc.
Valneva SE
Vaccitech plc

第 11 章分析師建議

命運之輪
分析師觀點
一致的機會圖

第12章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI4914

Global Vaccines Market is estimated to be valued at USD 81.91 Bn in 2025 and is expected to reach USD 124.88 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 81.91 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.20%	2032 Value Projection:	USD 124.88 Bn

Figure. Vaccines Market Share (%), By Region 2025

The global vaccines market has been witnessing steady growth over the past few years due to the rising prevalence of various infectious diseases and technological advancements in vaccine production. Vaccines aid in building immunity against specific diseases and allow populations at risk to be protected from the life-threatening effects of dangerous infections. Growing awareness about immunization, especially in developing nations is propelling the demand for advanced and affordable vaccines globally. Furthermore, the introduction of combination vaccines by major manufacturers is encouraging higher vaccination rates and reducing the burden on healthcare resources. Continued support from governments and international organizations towards immunization programs is expected to drive the global vaccines market growth during the forecast period.

Market Dynamics:

The global vaccines market is primarily driven by the rising incidence of infectious diseases, technological advancements in vaccine production, and growing focus on immunization programs by governments. According to the World Health Organization (WHO), immunization averts an estimated 2-3 million deaths annually. Mandates on vaccination of certain diseases and worldwide efforts towards disease eradication also provide momentum to market growth. However, high R&D costs associated with new vaccine development, stringent regulatory approvals, and vaccine hesitancy due to misinformation are some of the factors hindering the widespread adoption of vaccines. On the other hand, development of thermostable vaccines that can withstand high temperatures without refrigeration, cell-based vaccine technologies offering protection against mutating viruses, and initiatives to drive vaccine uptake in low and middle-income countries are expected to unlock lucrative opportunities for players in the coming years.

Key features of the study:

This report provides in-depth analysis of the global vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Merck, Sanofi Pasteur, GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, CSL Limited, and Serum Institute of India

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaccines market.

Detailed Segmentation-

By Type Insights (Revenue, USD Bn, 2020 - 2032)
- Monovalent Vaccines
- Mulitvalent Vaccines
By Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Conjugate Vaccines
- Recombinant Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Other Vaccine Technologies
By Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
- Tablets/Capsules
- Liquids
- Creams
- Gels
- Others
By Disease Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Pneumococcal Disease
- Influenza
- Combination Vaccines
- HPV
- Meningococcal Disease
- Herpes Zoster
- Rotavirus
- MMR
- Varicella
- Hepatitis
- DTP
- Polio
- RSV
- Other Disease Indications
By Route Of Administration: Insights (Revenue, USD Bn, 2020 - 2032)
- Intramuscular
- Subcutaneous
- Oral
- Intranasal
By Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline plc (GSK)
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Moderna, Inc.
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- CSL Limited
- Emergent BioSolutions Inc.
- Bharat Biotech
- Serum Institute of India
- BioNTech SE
- Takeda Pharmaceutical Company
- Sinovac Biotech Ltd.
- Sinopharm (China National Pharmaceutical Group)
- Vaxart, Inc.
- Inovio Pharmaceuticals, Inc.
- Valneva SE
- Vaccitech plc

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Vaccines Market, By Type
- Global Vaccines Market, By Technology
- Global Vaccines Market, By Dosage Form
- Global Vaccines Market, By Disease Indication
- Global Vaccines Market, By Route of Administration
- Global Vaccines Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Vaccines Market, By Type, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Monovalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Multivalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Vaccines Market, By Technology, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inactivated and Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Vaccine Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Vaccines Market, By Dosage Form, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Tablets/Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Liquids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Vaccines Market, By Disease Indication, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Pneumococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Combination Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HPV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Meningococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Herpes Zoster
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rotavirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
MMR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Varicella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
DTP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Polio
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
RSV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Disease Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Vaccines Market, By Route of Administration, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Vaccines Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa

10. COMPETITIVE LANDSCAPE

GlaxoSmithKline plc (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Moderna, Inc.
AstraZeneca
Johnson & Johnson
Novavax, Inc.
CSL Limited
Emergent BioSolutions Inc.
Bharat Biotech
Serum Institute of India
BioNTech SE
Takeda Pharmaceutical Company
Sinovac Biotech Ltd.
Sinopharm (China National Pharmaceutical Group)
Vaxart, Inc.
Inovio Pharmaceuticals, Inc.
Valneva SE
Vaccitech plc